ConductScience.org, home

Paper1707752

Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.

Parker WB and 9 others. Cancer Res, 1991. Cited by 207 papers, by iCite.

Cite this record

ConductScience Library. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate. Papers, record 1707752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1707752

Download JSON
Disease
acute myeloid leukemia587 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
PubMed
Journal
Cancer Res
PubMed
Year
1991
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
207
iCite
Relative citation ratio, by iCite
5.29
iCite
Revised in PubMed
2018-11-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parker WBW B
2Shaddix SCS C
3Chang CHC H
4White ELE L
5Rose LML M
6Brockman RWR W
7Shortnacy ATA T
8Montgomery JAJ A
9Secrist JA 3rdJ A
10Bennett LL JrL L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArabinonucleosidesMajor topic
DNAMajor topic
Nucleic Acid Synthesis InhibitorsMajor topic
Ribonucleotide ReductasesMajor topic
Adenine Nucleotides
Adenosine Triphosphate
Cell Division
Clofarabine
Cytidine Triphosphate
Deoxycytidine
Guanidine
Guanidines
Humans
RNA
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA34200NCI NIH HHSUnited StatesP01CA034200PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00700011Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)Results

Source ClinicalTrials.gov

Download CSV of trials

Cited by78

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.

PMIDTitleJournalYearIn PapersSource
41890705Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.Blood Neoplasia2026https://conductscience.org/library/papers/41890705PubMed
41881963The oncogenic control of nucleotide synthesis.Oncogenesis2026https://conductscience.org/library/papers/41881963PubMed
40615230Ribonucleotide reductase (RNR) inhibitors as target-based weapon for future cancer drug development.Future Med Chem2025https://conductscience.org/library/papers/40615230PubMed
40434346Clofarabine Enhances the Transduction Efficiency of Recombinant AAV2 in the Retina.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40434346PubMed
40142132Synthesis of Adenine Nucleosides with a Reactive (β-Iodovinyl)sulfone or (β-Keto)sulfone Group at the C2 Position and Their Polymerase-Catalyzed Incorporation into DNA.Molecules2025https://conductscience.org/library/papers/40142132PubMed
39189649Connecting dots between nucleotide biosynthesis and DNA lesion repair/bypass in cancer.Biosci Rep2024https://conductscience.org/library/papers/39189649PubMed
38936939In Vivo Cytotoxic, Genotoxic and Radiosensitizing Effects of Clofarabine.In Vivo2024https://conductscience.org/library/papers/38936939PubMed
36151376Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update.Subcell Biochem2022https://conductscience.org/library/papers/36151376PubMed
35740940Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.Biomolecules2022https://conductscience.org/library/papers/35740940PubMed
345039945-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.J Pharmacol Exp Ther2021https://conductscience.org/library/papers/34503994PubMed
31950591Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.EMBO Mol Med2020https://conductscience.org/library/papers/31950591PubMed
31637757Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.Am J Hematol2020https://conductscience.org/library/papers/31637757PubMed
30734609Structure-guided design of anti-cancer ribonucleotide reductase inhibitors.J Enzyme Inhib Med Chem2019https://conductscience.org/library/papers/30734609PubMed
29750747Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms.J Pediatr Hematol Oncol2018https://conductscience.org/library/papers/29750747PubMed
29123979Inhibition of nonenzymatic depurination of nucleic acids by polycations.FEBS Open Bio2017https://conductscience.org/library/papers/29123979PubMed
28624910Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?J Cancer Res Clin Oncol2017https://conductscience.org/library/papers/28624910PubMed
28394191The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells.Leuk Lymphoma2017https://conductscience.org/library/papers/28394191PubMed
28283480Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.Blood2017https://conductscience.org/library/papers/28283480PubMed
27960273Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.Chem Rev2016https://conductscience.org/library/papers/27960273PubMed
278790472-Substituted dATP Derivatives as Building Blocks for Polymerase-Catalyzed Synthesis of DNA Modified in the Minor Groove.Angew Chem Int Ed Engl2016https://conductscience.org/library/papers/27879047PubMed

See all 78 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DCK1633PubTator's text mininghttps://conductscience.org/library/genes/1633NCBI Gene
POLA15422PubTator's text mininghttps://conductscience.org/library/genes/5422NCBI Gene
POLB5423PubTator's text mininghttps://conductscience.org/library/genes/5423NCBI Gene
POLG5428PubTator's text mininghttps://conductscience.org/library/genes/5428NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
CLOFARABINECHEMBL1750Results1https://conductscience.org/library/drugs/CHEMBL1750

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1707752

GET https://conductscience.org/api/papers/v1/1707752/cited_by?page=2